Lipids and bariatric procedures Part 2 of 2: Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)

Harold Bays; Shanu N. Kothari; Dan E. Azagury; John M. Morton; Ninh T. Nguyen; Peter H. Jones; Terry A. Jacobson; David E. Cohen; Carl Orringer; Eric C. Westman; Deborah B. Horn; Wendy Scinta; Craig Primack

doi:10.1016/j.soard.2016.01.007

Lipids and bariatric procedures Part 2 of 2: Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)

Harold Bays, Shanu N. Kothari, Dan E. Azagury, John M. Morton, Ninh T. Nguyen, Peter H. Jones, Terry A. Jacobson, David E. Cohen, Carl Orringer, Eric C. Westman, Deborah B. Horn, Wendy Scinta, Craig Primack

Medicine

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

Bariatric procedures generally improve dyslipidemia, sometimes substantially so. Bariatric procedures also improve other major cardiovascular risk factors. This 2-part Scientific Statement examines the lipid effects of bariatric procedures and reflects contributions from authors representing the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and the Obesity Medicine Association (OMA). Part 1 was published in the Journal of Clinical Lipidology, and reviewed the impact of bariatric procedures upon adipose tissue endocrine and immune factors, adipose tissue lipid metabolism, as well as the lipid effects of bariatric procedures relative to bile acids and intestinal microbiota. This Part 2 reviews: (1) the importance of nutrients (fats, carbohydrates, and proteins) and their absorption on lipid levels; (2) the effects of bariatric procedures on gut hormones and lipid levels; (3) the effects of bariatric procedures on nonlipid cardiovascular disease (CVD) risk factors; (4) the effects of bariatric procedures on lipid levels; (5) effects of bariatric procedures on CVD; and finally, (6) the potential lipid effects of vitamin, mineral, and trace element deficiencies, that may occur after bariatric procedures.

Original language	English (US)
Pages (from-to)	468-495
Number of pages	28
Journal	Surgery for Obesity and Related Diseases
Volume	12
Issue number	3
DOIs	https://doi.org/10.1016/j.soard.2016.01.007
State	Published - Mar 1 2016

Keywords

Adiposopathy
Bariatric procedures
Bariatric surgery
Cardiovascular disease
Cholesterol
Dyslipidemia
Gastrointestinal hormones
Micronutrients
Nutrition
Obesity
Vitamins

ASJC Scopus subject areas

Surgery

Access to Document

10.1016/j.soard.2016.01.007

Fingerprint

Dive into the research topics of 'Lipids and bariatric procedures Part 2 of 2: Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)'. Together they form a unique fingerprint.

Cite this

Bays, H., Kothari, S. N., Azagury, D. E., Morton, J. M., Nguyen, N. T., Jones, P. H., Jacobson, T. A., Cohen, D. E., Orringer, C., Westman, E. C., Horn, D. B., Scinta, W., & Primack, C. (2016). Lipids and bariatric procedures Part 2 of 2: Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA). Surgery for Obesity and Related Diseases, 12(3), 468-495. https://doi.org/10.1016/j.soard.2016.01.007

Lipids and bariatric procedures Part 2 of 2 : Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA). / Bays, Harold; Kothari, Shanu N.; Azagury, Dan E.; Morton, John M.; Nguyen, Ninh T.; Jones, Peter H.; Jacobson, Terry A.; Cohen, David E.; Orringer, Carl; Westman, Eric C.; Horn, Deborah B.; Scinta, Wendy; Primack, Craig.

In: Surgery for Obesity and Related Diseases, Vol. 12, No. 3, 01.03.2016, p. 468-495.

Research output: Contribution to journal › Article › peer-review

Bays, H, Kothari, SN, Azagury, DE, Morton, JM, Nguyen, NT, Jones, PH, Jacobson, TA, Cohen, DE, Orringer, C, Westman, EC, Horn, DB, Scinta, W & Primack, C 2016, 'Lipids and bariatric procedures Part 2 of 2: Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)', Surgery for Obesity and Related Diseases, vol. 12, no. 3, pp. 468-495. https://doi.org/10.1016/j.soard.2016.01.007

Bays H, Kothari SN, Azagury DE, Morton JM, Nguyen NT, Jones PH et al. Lipids and bariatric procedures Part 2 of 2: Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA). Surgery for Obesity and Related Diseases. 2016 Mar 1;12(3):468-495. https://doi.org/10.1016/j.soard.2016.01.007

Bays, Harold ; Kothari, Shanu N. ; Azagury, Dan E. ; Morton, John M. ; Nguyen, Ninh T. ; Jones, Peter H. ; Jacobson, Terry A. ; Cohen, David E. ; Orringer, Carl ; Westman, Eric C. ; Horn, Deborah B. ; Scinta, Wendy ; Primack, Craig. / Lipids and bariatric procedures Part 2 of 2 : Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA). In: Surgery for Obesity and Related Diseases. 2016 ; Vol. 12, No. 3. pp. 468-495.

@article{8e977738853747b09c1a11e4067ac8da,

title = "Lipids and bariatric procedures Part 2 of 2: Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)",

abstract = "Bariatric procedures generally improve dyslipidemia, sometimes substantially so. Bariatric procedures also improve other major cardiovascular risk factors. This 2-part Scientific Statement examines the lipid effects of bariatric procedures and reflects contributions from authors representing the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and the Obesity Medicine Association (OMA). Part 1 was published in the Journal of Clinical Lipidology, and reviewed the impact of bariatric procedures upon adipose tissue endocrine and immune factors, adipose tissue lipid metabolism, as well as the lipid effects of bariatric procedures relative to bile acids and intestinal microbiota. This Part 2 reviews: (1) the importance of nutrients (fats, carbohydrates, and proteins) and their absorption on lipid levels; (2) the effects of bariatric procedures on gut hormones and lipid levels; (3) the effects of bariatric procedures on nonlipid cardiovascular disease (CVD) risk factors; (4) the effects of bariatric procedures on lipid levels; (5) effects of bariatric procedures on CVD; and finally, (6) the potential lipid effects of vitamin, mineral, and trace element deficiencies, that may occur after bariatric procedures.",

keywords = "Adiposopathy, Bariatric procedures, Bariatric surgery, Cardiovascular disease, Cholesterol, Dyslipidemia, Gastrointestinal hormones, Micronutrients, Nutrition, Obesity, Vitamins",

author = "Harold Bays and Kothari, {Shanu N.} and Azagury, {Dan E.} and Morton, {John M.} and Nguyen, {Ninh T.} and Jones, {Peter H.} and Jacobson, {Terry A.} and Cohen, {David E.} and Carl Orringer and Westman, {Eric C.} and Horn, {Deborah B.} and Wendy Scinta and Craig Primack",

note = "Funding Information: Harold Bays, M.D., is not a bariatric surgeon and has no industry disclosures regarding bariatric procedures. However, regarding other disclosures, in the past 12 months, Dr. Harold Bays{\textquoteright} research site has received research grants from Amarin, Amgen, Ardea, Arisaph, Catabasis, Cymabay, Eisai, Elcelyx, Eli Lilly, Esperion, Hanmi, Hisun, Hoffman LaRoche, Home Access, Janssen, Johnson and Johnson, Merck, Necktar, Novartis, Novo Nordisk, Omthera, Orexigen, Pfizer, Pronova, Regeneron, Sanofi, Takeda, and TIMI. In the past 12 months, Dr. Harold Bays has served as a consultant and/or speaker to Alnylam, Amarin, Amgen, Astra Zeneca, Eisai, Eli Lilly, Merck, Novartis, NovoNordisk, Regeneron, Sanofi and Takeda. Publisher Copyright: {\textcopyright} 2016 American Society for Bariatric Surgery.",

year = "2016",

month = mar,

day = "1",

doi = "10.1016/j.soard.2016.01.007",

language = "English (US)",

volume = "12",

pages = "468--495",

journal = "Surgery for Obesity and Related Diseases",

issn = "1550-7289",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Lipids and bariatric procedures Part 2 of 2

T2 - Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)

AU - Bays, Harold

AU - Kothari, Shanu N.

AU - Azagury, Dan E.

AU - Morton, John M.

AU - Nguyen, Ninh T.

AU - Jones, Peter H.

AU - Jacobson, Terry A.

AU - Cohen, David E.

AU - Orringer, Carl

AU - Westman, Eric C.

AU - Horn, Deborah B.

AU - Scinta, Wendy

AU - Primack, Craig

N1 - Funding Information: Harold Bays, M.D., is not a bariatric surgeon and has no industry disclosures regarding bariatric procedures. However, regarding other disclosures, in the past 12 months, Dr. Harold Bays’ research site has received research grants from Amarin, Amgen, Ardea, Arisaph, Catabasis, Cymabay, Eisai, Elcelyx, Eli Lilly, Esperion, Hanmi, Hisun, Hoffman LaRoche, Home Access, Janssen, Johnson and Johnson, Merck, Necktar, Novartis, Novo Nordisk, Omthera, Orexigen, Pfizer, Pronova, Regeneron, Sanofi, Takeda, and TIMI. In the past 12 months, Dr. Harold Bays has served as a consultant and/or speaker to Alnylam, Amarin, Amgen, Astra Zeneca, Eisai, Eli Lilly, Merck, Novartis, NovoNordisk, Regeneron, Sanofi and Takeda. Publisher Copyright: © 2016 American Society for Bariatric Surgery.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Bariatric procedures generally improve dyslipidemia, sometimes substantially so. Bariatric procedures also improve other major cardiovascular risk factors. This 2-part Scientific Statement examines the lipid effects of bariatric procedures and reflects contributions from authors representing the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and the Obesity Medicine Association (OMA). Part 1 was published in the Journal of Clinical Lipidology, and reviewed the impact of bariatric procedures upon adipose tissue endocrine and immune factors, adipose tissue lipid metabolism, as well as the lipid effects of bariatric procedures relative to bile acids and intestinal microbiota. This Part 2 reviews: (1) the importance of nutrients (fats, carbohydrates, and proteins) and their absorption on lipid levels; (2) the effects of bariatric procedures on gut hormones and lipid levels; (3) the effects of bariatric procedures on nonlipid cardiovascular disease (CVD) risk factors; (4) the effects of bariatric procedures on lipid levels; (5) effects of bariatric procedures on CVD; and finally, (6) the potential lipid effects of vitamin, mineral, and trace element deficiencies, that may occur after bariatric procedures.

AB - Bariatric procedures generally improve dyslipidemia, sometimes substantially so. Bariatric procedures also improve other major cardiovascular risk factors. This 2-part Scientific Statement examines the lipid effects of bariatric procedures and reflects contributions from authors representing the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and the Obesity Medicine Association (OMA). Part 1 was published in the Journal of Clinical Lipidology, and reviewed the impact of bariatric procedures upon adipose tissue endocrine and immune factors, adipose tissue lipid metabolism, as well as the lipid effects of bariatric procedures relative to bile acids and intestinal microbiota. This Part 2 reviews: (1) the importance of nutrients (fats, carbohydrates, and proteins) and their absorption on lipid levels; (2) the effects of bariatric procedures on gut hormones and lipid levels; (3) the effects of bariatric procedures on nonlipid cardiovascular disease (CVD) risk factors; (4) the effects of bariatric procedures on lipid levels; (5) effects of bariatric procedures on CVD; and finally, (6) the potential lipid effects of vitamin, mineral, and trace element deficiencies, that may occur after bariatric procedures.

KW - Adiposopathy

KW - Bariatric procedures

KW - Bariatric surgery

KW - Cardiovascular disease

KW - Cholesterol

KW - Dyslipidemia

KW - Gastrointestinal hormones

KW - Micronutrients

KW - Nutrition

KW - Obesity

KW - Vitamins

UR - http://www.scopus.com/inward/record.url?scp=84961932958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961932958&partnerID=8YFLogxK

U2 - 10.1016/j.soard.2016.01.007

DO - 10.1016/j.soard.2016.01.007

M3 - Article

C2 - 27050404

AN - SCOPUS:84961932958

VL - 12

SP - 468

EP - 495

JO - Surgery for Obesity and Related Diseases

JF - Surgery for Obesity and Related Diseases

SN - 1550-7289

IS - 3

ER -

Lipids and bariatric procedures Part 2 of 2: Scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this